Literature DB >> 13457528

New aspects of ophthalmoneurologic diagnosis.

G M BREININ.   

Abstract

Keywords:  ELECTROMYOGRAPHY; EYE DISEASES/diagnosis

Mesh:

Year:  1957        PMID: 13457528     DOI: 10.1001/archopht.1957.00940010387010

Source DB:  PubMed          Journal:  AMA Arch Ophthalmol        ISSN: 0096-6339


× No keyword cloud information.
  14 in total

1.  Management of traumatic lateral rectus paralysis.

Authors:  W P CHAMBERLAIN
Journal:  Trans Am Ophthalmol Soc       Date:  1958

2.  Electromyography in intermittent exotropia; recordings before, during and after corrective operation.

Authors:  F C BLODI; M W VAN ALLEN
Journal:  Doc Ophthalmol       Date:  1962       Impact factor: 2.379

3.  Ocular Manifestations of Thyroid Disease: Current Concepts.

Authors:  R M Day
Journal:  Trans Am Ophthalmol Soc       Date:  1959

4.  True and simulated superior oblique tendon sheath syndromes.

Authors:  H W Brown
Journal:  Doc Ophthalmol       Date:  1973-02-21       Impact factor: 2.379

5.  Superior oblique tendon sheath syndrome and its relationship to stenosing tenosynovitis.

Authors:  J H Sandford-Smith
Journal:  Br J Ophthalmol       Date:  1973-11       Impact factor: 4.638

6.  Congenital ophthalmoplegia. A myopathic aetiology in two siblings.

Authors:  L J Hurwitz; C J Maguire; T Fannin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-08       Impact factor: 10.154

7.  Stretch reflex in an extra-ocular muscle. Electromyographic findings in a case of orbital fracture.

Authors:  I Nawratzki; H Zauberman; A Magora; J Chaco
Journal:  Br J Ophthalmol       Date:  1968-06       Impact factor: 4.638

8.  Ocular muscle surgery in Graves' disease.

Authors:  J A Dyer
Journal:  Trans Am Ophthalmol Soc       Date:  1978

9.  The oculorotary muscles in Graves' disease.

Authors:  J A Dyer
Journal:  Trans Am Ophthalmol Soc       Date:  1976

10.  Superior oblique tendon sheath syndrome. An electromyographical study.

Authors:  G V Catford; J C Hart
Journal:  Br J Ophthalmol       Date:  1971-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.